Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In a surprise touch, the founder and former CEO of 23andme, Anne Wojcicki, should regain control of the assets of the DNA company, According to a press release 23andme. In May, a company called Regeneron bought 23andm for $ 256 million In a bankruptcy auction, but the non -profit organization in Wojcicki, the TTAM Research Institute, was able to reopen the auctions with an “unsolicited offer” of $ 305 million, The Wall Street Journal reports.
A bankruptcy judge has agreed to reopen the auctions out of 23ands under the condition that the price offered by Regeneron Top Wojcicki of at least $ 10 million, according to in Wsj. Regeneron refused, leaving 23and in the control of TTAM assuming that the judge approves the agreement. A hearing to consider the new agreement is set for June 17, 2025.
Regeneron had previously planned to keep all the employees of the company and continue to offer DNA test kits to consumers. In addition to answering customers’ questions about their ancestry, the genetic data of 23andm is precious as a means of identifying possible health risks, and in the case of Regeneron, as a tool for identifying medication targets.
We do not completely know what Wojcicki intends to do next, but the 23andme announcement includes a list of customer data and privacy protection TTAM Research Institute has accepted, in particular by continuing to allow customers to delete their data and disabuse themselves of research, to establish a board of directors of consumer life – unless you are sold or transferred data “in case of bankruptcy.
Maintaining the control of the company’s assets has been Wojcicki’s plan for 23 and Bankruptcy declared In March 2025. She initially resigned from her company CEO to make an offer on the company.
“I am delighted that the TTAM Research Institute is able to continue the mission of 23andm to help people access, understand and benefit from the human genome,” explains Wojcicki. “We believe that it is essential that individuals are authorized to have the choice and transparency with regard to their genetic data and to have the possibility of continuing to know more about their risks of ancestry and health as they wish.”
23andme had a few years turbulent before declaring bankruptcy, undergoing a data violation in 2023 which had an impact millions of customers and mass layoffs in 2024 It affected 40% company staff.
If you buy something via a link in this article, we can win a commission.
